| Sponsor Message: |
 |
FDA Releases 2018 NARMS Integrated Summary and NARMS Now: Integrated Data Featuring Genomic Data and Predicted Resistance
December 15, 2020 —
Today, the U.S. Food and Drug Administration, in cooperation with the U.S. Centers for Disease Control and Prevention (CDC), and the U.S. Department of Agriculture's Food Safety and Inspection Service (USDA-FSIS), its partners in the National Antimicrobial Resistance Monitoring System (NARMS), is releasing the 2018 NARMS Integrated Summary and NARMS Now: Integrated Data featuring predictive resistance functionality from genomic data. [Source: FDA 11 December 2020]
NARMS is a national public health surveillance system that monitors enteric bacteria and select animal pathogens to determine if they are resistant to antimicrobials used in human and veterinary medicine. The NARMS program helps promote and protect public health by providing information on whether bacterial resistance in the food chain is increasing or decreasing and on the impact of interventions designed to limit the spread of resistance. FDA uses NARMS data to inform its policy development, decision making, and other activities focused on preserving the effectiveness of antimicrobials for humans and animals.
- Next story: Hogg Scholarship Available to Practitioner Pursuing a Graduate Degree
- Next in category: Swine Drug Summaries Available to AASV Members
- Previous in category: FDA Releases Annual Summary Report on Antimicrobials Sold or Distributed in 2019 for Use in Food-Producing Animals
- Previous story: FDA Approves First-of-its-Kind Intentional Genomic Alteration in Line of Domestic Pigs for Both Human Food, Potential Therapeutic Uses